Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06345664
Other study ID # 548/2022BO1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2023
Est. completion date December 2024

Study information

Verified date April 2024
Source University Hospital Tuebingen
Contact Annette Conzelmann, Prof. Dr.
Phone 004970712987513
Email annette.conzelmann@med.uni-tuebingen.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to assess mental and somatic symptoms of preterm born children at the ages of 2, 5 and 10 by a multidisciplinary team and to evaluate an app that screens for these symptoms. Furthermore, there will be an evaluation of an intervention by our multidisciplinary team that provides recommendations for further treatment and diagnostic procedures of the children.


Description:

- At first, there will be focus groups with experts and affected families to finalize and optimize the study procedure. After that, 90 children will be recruited (ages 2, 5 and 10) - T0: App-questions for the children at the ages of 5 and 10 and the parents of all children to mental, somatic and sleep problems of the children and well-being of the parents, sleep tracking and recording of a sleep sequence of the children; differentiated examinations and questionnaires to mental and somatic problems of the children by interdisciplinary study team - Interdisciplinary study team meeting to generate recommendations for the families - Interdisciplinary study team recommendations for the families - T1: Comparable to T0 but only measurements that were assessed with questionnaires/at home plus post-experimental questionnaire - Focus groups with participating families and the study team experts for evaluation of the study procedure and intervention


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 2024
Est. primary completion date October 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 10 Years
Eligibility Inclusion Criteria: - female and male preterm born children (<32 week of pregnancy) that are treated at the clinic in Tübingen and their parents - Existence of systematical neonatal data and consent of the care person to use this data - Existence of the data of the 2 year regular follow-up (for the 5 and 10 year olds) Exclusion Criteria: - lack of access to a mobile phone/tablet including internet access - insufficient knowledge of the German language of both parents

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Diagnostics and intervention recommendations
All families get the same diagnostics and receive individual treatment recommendations.

Locations

Country Name City State
Germany University Hospital Tuebingen Tuebingen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bayley Scales of Infant and Toddler Development IQ testing Baseline
Primary Wechsler Intelligence Scale for Children (WISC-V) IQ testing Baseline
Primary Children's Sleep Habit Questionnaire (CSHQ-DE 4-10) Screening of sleeping behaviour Baseline and 36-38 weeks after baseline
Primary Sleep Self Report (SSR) Screening of sleeping behaviour Baseline and 36-38 weeks after baseline
Primary Somatics Questions to somatic symptoms (diagnoses, inpatient stays, medication, early support) physical therapy, hearing impairment or visual disturbance, pulmonary symptoms, seizure disorders, health related quality of life, body weight, size) Baseline and 36-38 weeks after baseline
Primary Child Behavior Checklist (CBCL) Screening for mental illness Baseline and 36-38 weeks after baseline
Primary Youth Self Report (YSR) Screening for mental illness Baseline and 36-38 weeks after baseline
Primary Diagnostic-system for mental illness for children and adolescents - III (DISYPS-III SCREEN FBB and SBB) Screening for mental illness Baseline and 36-38 weeks after baseline
Primary KIDSCREEN-27 (The KIDSCREEN) Health related quality of life Baseline and 36-38 weeks after baseline
Primary Parent's Stress Inventory (EBI) Load as parents and relationship to the child Baseline and 36-38 weeks after baseline
Primary App-questions Questions reflecting the questionnaires Baseline and 36-38 weeks after baseline
Primary Postexperimental questionnaire Evaluation of the study 36-38 weeks after baseline
Secondary Demographic data age, gender, ethnicity, perinatal data from previous study participation Baseline
Secondary Actigraphy measurement Device that the children are wearing at their wrists Baseline
Secondary Video of a sleeping sequence The parents are taking a short video sequence of their sleeping child Baseline
Secondary Sleep cartoon for children Cartoon sleep behavior Baseline and 36-38 weeks after baseline
Secondary Kiddie-Sads-Present and Lifetime Version (K-SADS PL) Screening mental Illness Baseline
Secondary Self efficacy dealing with social situations (WIRKSOZ) Self-efficacy measurement for social situations in children Baseline and 36-38 weeks after baseline
Secondary Group interviews Group interviews with experts and families to get feedback about the study procedure and needs Baseline and 36-38 weeks after baseline
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04021654 - What is the Future of Vulnerable New-borns